Stock Fundamentals

Company Information

Company Name
ADMA Biologics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US0008991046
CIK: 0001368514
CUSIP: 000899104
Currency: USD
Full Time Employees: 677
Phone: 201-478-5552
Fiscal Year End: December
IPO Date: Oct 17, 2013
Description:

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Address:

465 State Route 17, Ramsey, NJ, United States, 07446

Directors & Officers

Name Title Year Born
Mr. Adam S. Grossman Co-Founder, President, CEO & Director 1977
Dr. Jerrold B. Grossman D.P.S., Ph.D. Co-Founder & Vice Chairman of the Board 1948
Ms. Kaitlin Kestenberg COO & Senior VP of Compliance 1987
Mr. Brad Tade Consultant 1974
Mr. P. Terence Kohler CFO & Treasurer NA
Mr. Michael Goldstein General Counsel NA
Mr. John Hafl Executive Director of Sales NA
Mr. Skyler Bloom Senior Director of Business Development & Corporate Strategy NA

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 35.63M Sep 30, 2025 14.97% $0.01 -2.31%
Vanguard Group Inc 20.85M Dec 31, 2025 8.76% $0.01 -0.57%
State Street Corp 13.56M Sep 30, 2025 5.70% $0.01 12.28%
Amvescap Plc. 12.51M Sep 30, 2025 5.25% $0.03 -2.44%
Sachem Head Capital Management LP 11.38M Dec 31, 2025 4.78% $4.86 26.95%
Westfield Capital Management Company, L.P. 6.99M Dec 31, 2025 2.94% $0.53 36.93%
Geode Capital Management, LLC 5.81M Sep 30, 2025 2.44% $0.01 -1.68%
Nuveen, LLC 5.72M Sep 30, 2025 2.41% $0.02 2.90%
American Century Companies Inc 5.20M Dec 31, 2025 2.18% $0.05 10.70%
Dimensional Fund Advisors, Inc. 4.84M Dec 31, 2025 2.03% $0.02 0.78%
Thrivent Financial For Lutherans 4.14M Sep 30, 2025 1.74% $0.12 24.93%
Capital Research Global Investors 3.25M Sep 30, 2025 1.37% $0.01 0.00%
The Goldman Sachs Group Inc 2.91M Sep 30, 2025 1.22% $0.01 59.90%
Franklin Resources Inc 2.84M Sep 30, 2025 1.19% $0.03 4.38%
Caligan Partners LP 2.64M Sep 30, 2025 1.11% $5.06 0.00%
B Group, Inc 2.46M Dec 31, 2025 1.03% $33.10 1.87%
Northern Trust Corp 2.36M Sep 30, 2025 0.99% $0.00 -3.38%
Ranger Investment Management LP 2.30M Dec 31, 2025 0.97% $2.88 -1.70%
Charles Schwab Investment Management Inc 2.26M Dec 31, 2025 0.95% $0.01 -4.37%
Awm Investment Company Inc 2.20M Dec 31, 2025 0.92% $3.88 0.00%

Shares Statistics

Shares Outstanding: 238.00M
Shares Float: 233.40M
% Insiders: 321.30%
% Institutions: 9,471.50%
Short % Float: 10.87%

🏆 Top 10 Institutional Holders

Rank Holder Name Shares Held % of Shares Change Date Reported
1 BlackRock Inc 35.63M 14.97% ▼ 2.31% Sep 30, 2025
2 Vanguard Group Inc 20.85M 8.76% ▼ 0.57% Dec 31, 2025
3 State Street Corp 13.56M 5.70% ▲ 12.28% Sep 30, 2025
4 Amvescap Plc. 12.51M 5.25% ▼ 2.44% Sep 30, 2025
5 Sachem Head Capital Management LP 11.38M 4.78% ▲ 26.95% Dec 31, 2025
6 Westfield Capital Management Company, L.P. 6.99M 2.94% ▲ 36.93% Dec 31, 2025
7 Geode Capital Management, LLC 5.81M 2.44% ▼ 1.68% Sep 30, 2025
8 Nuveen, LLC 5.72M 2.41% ▲ 2.90% Sep 30, 2025
9 American Century Companies Inc 5.20M 2.18% ▲ 10.70% Dec 31, 2025
10 Dimensional Fund Advisors, Inc. 4.84M 2.03% ▲ 0.78% Dec 31, 2025

Valuation Metrics

Enterprise Value: $3.73B
Trailing P/E: 18.10
Forward P/E: 28.99

Financial Highlights

Market Cap: $3.72B
EBITDA: $199.54M
P/E Ratio: $18.10
PEG Ratio: $0.00
Book Value: $2.01
Earnings/Share: $0.86
Profit Margin: 28.80%
Operating Margin: 45.09%
ROA (TTM): 21.50%
ROE (TTM): 35.56%
Revenue (TTM): $510.17M
Revenue/Share (TTM): $2.14
Earnings Growth (YOY): -52.80%
Revenue Growth (YOY): 18.40%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios (Yearly)

Financial Ratios (Quarterly)

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 6.71x 0.01x 0.24x 26.93x 0.02x
2024-12-31 5.97x 0.21x 0.29x 9.98x 0.50x
2023-12-31 5.16x 0.97x 0.59x 0.86x 25.71x
2022-12-31 6.89x 0.95x 0.56x -2.04x -3.64x
2021-12-31 6.87x 0.68x 0.49x -4.47x -1.80x
2020-12-31 7.71x 1.06x 0.58x -5.42x -1.56x
2019-12-31 6.12x 2.62x 0.79x -4.61x -1.90x
2018-12-31 4.63x 1.48x 0.78x -10.92x -0.52x
2017-12-31 6.69x 0.78x 0.63x -11.96x -0.80x
2016-12-31 1.93x -4.14x 1.19x -7.74x -1.10x
2015-12-31 5.05x 17.39x 0.97x -8.42x -0.91x
2014-12-31 5.74x 2.46x 0.78x -12.45x -0.93x
2013-12-31 8.49x 0.23x 0.33x -24.33x -0.33x
2012-12-31 7.68x 0.40x 0.39x -257.77x -0.49x
2011-12-31 1.52x 0.00x 0.66x N/A 0.00x
2010-12-31 0.97x 0.00x 1.03x N/A 0.00x
2009-12-31 0.75x 0.00x 1.00x N/A 0.00x
2008-12-31 0.17x 0.00x 1.00x N/A 0.00x
2007-12-31 1.45x 0.00x 1.00x N/A 0.00x
2006-12-31 1.45x N/A 1.00x N/A 0.00x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jun 16, 2025 Steve Elms N/A Sale 194.75K $20.24 $3.94M
Jun 13, 2025 Steve Elms N/A Sale 137.93K $20.82 $2.87M
Jun 12, 2025 Steve Elms N/A Sale 92.94K $21.69 $2.02M
Jun 09, 2025 Jerrold B Grossman N/A Sale 10.00K $21.31 $213.10K
Jun 09, 2025 Lawrence P Guiheen N/A Sale 20.00K $20.96 $419.20K
May 22, 2025 Lawrence P Guiheen N/A Sale 1.22K $20.12 $24.57K
May 21, 2025 Lawrence P Guiheen N/A Sale 7.78K $20.32 $158.07K

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ADMA.US!